MedPath

Effect of Standardized Nutritional Therapy on Clinical Prognosis and Cost-effectiveness of Inflammatory Bowel Disease

Not Applicable
Conditions
Inflammatory Bowel Disease
Registration Number
NCT04349943
Lead Sponsor
The Third Xiangya Hospital of Central South University
Brief Summary

To construct a standardized stepped nutritional treatment process for inpatients with inflammatory bowel disease, including nutritional risk screening and assessment, standardized nutritional treatment implementation, therapeutic effect follow-up and monitoring, family nutritional treatment follow-up, etc.

Detailed Description

Nutrition therapy of inflammatory bowel disease should follow the principle of sequential treatment of nutrition, which is the preferred scheme with enteral nutrition, from slow to fast, from weak to strong, from the elements to the whole protein on the steps of the gradual transition, in order to improve enteral nutrition in patients with tolerance and compliance and improve patient quality of life and long-term survival rate, reduce the social burden of disease, patients with good economic and social benefits.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients diagnosed with inflammatory bowel disease
Exclusion Criteria
  • nothing

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Improvement of nutritional status2 years

We collect the body composition and grip strength of every IBD patients. Body composition include the muscle and fat contents.They are all measured as kilogram. (kg). Specific nutritional guidelines will be provided based on body composition results.

Improvement of quality of life2 years

We asked each patient to complete the quality of life scale for every IBD patient. There are 32 questions in the scale, and each question has 7 options. The higher the score, the heavier it is.We will decide whether to give psychological intervention based on the score.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the Third Xiangya Hospital of Central South University

🇨🇳

Changsha, Hunan, China

the Third Xiangya Hospital of Central South University
🇨🇳Changsha, Hunan, China
Min Liu, M.D.
Principal Investigator
Hong Liu, M.M.
Contact
86-731-88618717
znxywm@163.com
Qin Guo, M.D.
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.